FEBRUARY 20, 2012

Browse Categories

European Urology -Validation of the Diagnostic Value of NMP22® BladderChek® Test as a Marker for Bladder Cancer by Photodynamic Diagnosis

Wed, 14 February 2007
E-mail Print
Volume 51, Issue 2, Pages 403-408 (February 2007)

Abstract -

Objectives:

The aim of the present study was to validate the sensitivity and specificity of the new “point-of-care” NMP22® BladderChek® test compared to photodynamic diagnosis (PDD).




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |